Aims and Scope of Drug Metabolism Reviews
Established in 1972, Drug Metabolism Reviews is an academic journal that publishes review articles on all aspects of drug metabolism research. It is the official journal of the International Society for the Study of Xenobiotics (ISSX). Less
Key Metrics
CiteScore 

8.8
Eigenfactor 

0.001 - 0.005
Impact Factor 

5 - 10
SJR 

Q1Pharmacology (medical)

SNIP 

1.62
Recommended pre-submission checks
Powered by 

Topics Covered on Drug Metabolism Reviews
Drug Metabolism Reviews Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | TAYLOR & FRANCIS LTD |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 1972 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Drug Metabolism Reviews ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Drug Metabolism Reviews
Metabolism of new drug modalities research advances – 2025 year in review
- 13 May 2026
- Drug Metabolism Reviews
Cytochrome P450-derived arachidonic acid metabolites as emerging therapeutic targets in menopause-associated cardiac hypertrophy
- 12 May 2026
- Drug Metabolism Reviews
Pharmacomicrobiomics in Precision Pharmacotherapy: Bidirectional Microbial-Drug Interactions as a Key Determinant of Therapeutic Response
- 7 May 2026
- Drug Metabolism Reviews
Population pharmacokinetics of levofloxacin: a systematic review
- 6 May 2026
- Drug Metabolism Reviews
Identification and characterization of a novel aldehyde metabolite of WIN18,446 and associated WIN18,446-ALDH1A2 protein adducts using mass spectrometry
- 6 May 2026
- Drug Metabolism Reviews
Exploring the clinical pharmacokinetics and pharmacodynamics of SGLT2 inhibitor, empagliflozin: a systematic review
- 6 May 2026
- Drug Metabolism Reviews
Metabolism of new drug modalities research advances – 2025 year in review
- 13 May 2026
- Drug Metabolism Reviews
Cytochrome P450-derived arachidonic acid metabolites as emerging therapeutic targets in menopause-associated cardiac hypertrophy
- 12 May 2026
- Drug Metabolism Reviews
Pharmacomicrobiomics in Precision Pharmacotherapy: Bidirectional Microbial-Drug Interactions as a Key Determinant of Therapeutic Response
- 7 May 2026
- Drug Metabolism Reviews
Population pharmacokinetics of levofloxacin: a systematic review
- 6 May 2026
- Drug Metabolism Reviews
Identification and characterization of a novel aldehyde metabolite of WIN18,446 and associated WIN18,446-ALDH1A2 protein adducts using mass spectrometry
- 6 May 2026
- Drug Metabolism Reviews
Exploring the clinical pharmacokinetics and pharmacodynamics of SGLT2 inhibitor, empagliflozin: a systematic review
- 6 May 2026
- Drug Metabolism Reviews